Skip to main content
Aurora Cannabis Inc. (ACB)
NASDAQ: ACB · IEX Real-Time Price · USD
6.70
-0.01 (-0.15%)
At close: Apr 26, 2024, 4:00 PM
6.66
-0.04 (-0.60%)
After-hours: Apr 26, 2024, 7:59 PM EDT

Aurora Cannabis Revenue

Aurora Cannabis had revenue of $200.73M in the twelve months ending December 31, 2023, with 30.77% growth year-over-year. Revenue in the quarter ending December 31, 2023 was $48.44M with 8.62% year-over-year growth. In the fiscal year ending June 30, 2022, Aurora Cannabis had annual revenue of $171.58M, a decrease of -13.25%.

Revenue (ttm)
$200.73M
Revenue Growth
+30.77%
P/S Ratio
0.52
Revenue / Employee
$177,639
Employees
1,130
Market Cap
105.37M USD

Revenue Chart

* The company reports in CAD currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 2022171.58M-26.20M-13.25%
Jun 30, 2021197.78M208.14K0.11%
Jun 30, 2020197.58M10.14M5.41%
Jun 30, 2019187.43M145.62M348.24%
Jun 30, 201841.82M40.71M3,677.60%
Jun 30, 20171.11M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Emergent BioSolutions 1.05B
TruBridge 339.44M
Seres Therapeutics 126.33M
CytomX Therapeutics 101.21M
Neuronetics 71.35M
Seer, Inc. 16.66M
Revenue Rankings

ACB News

More News